COLGATE TOTAL - ADVANCED HEALTH TOOTHPASTE

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

SODIUM FLUORIDE; TRICLOSAN

から入手可能:

COLGATE-PALMOLIVE CANADA INC

ATCコード:

A01AA51

INN（国際名）:

SODIUM FLUORIDE, COMBINATIONS

投薬量:

0.243%; 0.3%

医薬品形態:

TOOTHPASTE

構図:

SODIUM FLUORIDE 0.243%; TRICLOSAN 0.3%

投与経路:

DENTAL

パッケージ内のユニット:

85/170/18ML TUBE PASTE; 85/170ML TUBE GEL

処方タイプ:

OTC

治療領域:

DENTAL AGENTS

製品概要:

Active ingredient group (AIG) number: 0224632001; AHFS:

認証ステータス:

CANCELLED POST MARKET

承認日:

2019-08-01

製品の特徴

_ _
_Page 1 of 20_
PRODUCT MONOGRAPH
COLGATE TOTAL
Triclosan and Sodium Fluoride Toothpaste
0.3% Triclosan and 0.243% Sodium Fluoride
Control Number 130592, DIN 02044730
COLGATE TOTAL ADVANCED HEALTH
Triclosan and Sodium Fluoride Toothpaste
0.3% Triclosan and 0.243% Sodium Fluoride
Control Number 123143, DIN 02285568
COLGATE TOTAL ADVANCED HEALTH GUM DEFENSE
Triclosan and Sodium Fluoride Toothpaste
0.3% Triclosan and 0.243% Sodium Fluoride
Control Number 144026, DIN 02364786
Anticaries – Antiplaque – Antigingivitis - Anticalculus
Colgate-Palmolive Canada Inc.
Two Morneau Sobeco Centre, 6
th
Floor
895 Don Mills Road
Toronto, Ontario
M3C 1W3
Date of Revision:
June 25, 2013
Control Number: 163763
_ _
_Page 2 of 20_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
................................................... 3
SUMMARY PRODUCT INFORMATION
.............................................................. 3
INDICATIONS AND CLINICAL USE
.................................................................... 3
CONTRAINDICATIONS
.......................................................................................
3
WARNINGS AND PRECAUTIONS
......................................................................
3
ADVERSE REACTIONS
......................................................................................
4
DOSAGE AND ADMINISTRATION
......................................................................
4
OVERDOSAGE
....................................................................................................
4
ACTION AND CLINICAL PHARMACOLOGY
....................................................... 5
STORAGE AND
STABILITY.................................................................................
7
SPECIAL HANDLING INSTRUCTIONS
............................................................... 7
DOSAGE FORMS, COMPOSITION AND PACKAGING
...................................... 7
PART II: SCIENTIFIC INFORMATION
..........................................................................
8
PHARMACEU